BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18214794)

  • 1. The role of genetics in Graves' disease and thyroid orbitopathy.
    Kim N; Hatton MP
    Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
    Mourits MP
    Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
    [No Abstract]   [Full Text] [Related]  

  • 4. Etiopathogenesis of Graves' disease.
    Karasek M; Lewinski A
    Neuro Endocrinol Lett; 2003; 24(3-4):161-6. PubMed ID: 14523350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pro 12 Ala PPAR gamma gene polymorphism: possible modifier of the activity and severity of thyroid-associated orbitopathy (TAO).
    Alevizaki M; Mantzou E; Cimponeriu A; Saltiki K; Philippou G; Wiersinga W
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):464-8. PubMed ID: 18624999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic and environmental factors in Graves disease. A review].
    Brix TH; Kyvik KO; Hegedüs L
    Ugeskr Laeger; 1998 Jan; 160(5):616-21. PubMed ID: 9470466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of Graves' disease and Graves' orbitopathy.
    Nagayama Y; Nakahara M; Abiru N
    Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):381-6. PubMed ID: 26181432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Graves' orbitopathy.
    Putta-Manohar S; Perros P
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():182-5. PubMed ID: 20467360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis.
    Fonte R; Pirali B; Caramia V; Dionisio R; Lodigiani S; Sibilla L; Rotondi M; Chiovato L
    Thyroid; 2011 Dec; 21(12):1389-92. PubMed ID: 22066480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-199a Downregulation as a Driver of the NOX4/HIF-1α/VEGF-A Pathway in Thyroid and Orbital Adipose Tissues from Graves' Patients.
    Craps J; Joris V; Baldeschi L; Daumerie C; Camboni A; Buemi A; Lengelé B; Behets C; Boschi A; Mourad M; Many MC; Dessy C
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Orbit pathology and Graves' ophthalmopathy].
    Stankiewicz A
    Klin Oczna; 1997; 99(1):59-63. PubMed ID: 9379657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic risk markers in Graves' disease].
    Badenhoop K; Siegmund T; Mösseler S; Wenske I; Donner H; Usadel KH
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():11-5. PubMed ID: 10355043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy?
    Maurer E; Dănilă R; Dominguez E; Osei-Agymang T; Zielke A; Hassan I
    Chirurgia (Bucur); 2008; 103(3):291-5. PubMed ID: 18717277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
    Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
    Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?
    Bednarczuk T; Gopinath B; Ploski R; Wall JR
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):3-19. PubMed ID: 17521325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New perspectives for the diagnosis and prognosis of Graves' disease].
    Tatulashvili S; Baudry C; Sadoul JL; Bihan H
    Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S31-S39. PubMed ID: 30213303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
    Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
    Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.